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Abstract
 
Genetic ablation of the Lyn tyrosine kinase has revealed unique inhibitory roles in B lympho-
cyte signaling. We now report the consequences of sustained activation of Lyn in vivo using a
targeted gain-of-function mutation (Lyn
 
up/up 
 
mice). Lyn
 
up/up 
 
mice have reduced numbers of
conventional B lymphocytes, down-regulated surface immunoglobulin M and costimulatory
molecules, and elevated numbers of B1a B cells. Lyn
 
up/up 
 
B cells are characterized by the consti-
tutive phosphorylation of negative regulators of B cell antigen receptor (BCR) signaling in-
cluding CD22, SHP-1, and SHIP-1, and display attributes of lymphocytes rendered tolerant by
constitutive engagement of the antigen receptor. However, exaggerated positive signaling is
also apparent as evidenced by the constitutive phosphorylation of Syk and phospholipase C
 
 
 
2
in resting Lyn
 
up/up 
 
B cells. Similarly, Lyn
 
up/up 
 
B cells show a heightened calcium flux in response
to BCR stimulation. Surprisingly, Lyn
 
up/up 
 
mice develop circulating autoreactive antibodies
and lethal autoimmune glomerulonephritis, suggesting that enhanced positive signaling eventu-
ally overrides constitutive negative signaling. These studies highlight the difficulty in main-
taining tolerance in the face of chronic stimulation and emphasize the pivotal role of Lyn in B
cell signaling.
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Introduction
 
The nature of the B cell response to antigen depends on
the state of differentiation of the B cell, the composition,
concentration, and valence of the antigen, and the cellular
environment (1). In its most basic manifestation, this infor-
mation is processed to allow immune responses to foreign
antigens and tolerance to self. Information about antigens is
gathered by molecules on the surface of immune cells and
transmitted through various signaling pathways into the cell
nucleus to induce a cellular response. Some signaling path-
ways are stimulatory and others are inhibitory and it is the
integration of these signals that generates an outcome appro-
priate to the circumstance, be that an immune response or
tolerance. An imbalance between the positive and negative
signals, on the other hand, could result in an inappropriate
response leading to autoimmunity or immune deficiency.
For example, mice with altered dosages of genes encoding
B cell inhibitory and costimulatory receptors such as
CD22, PD-1, Fc
 
 
 
RIIb1, and CD19, all of which play key
roles in modulating the strength of the B cell antigen re-
ceptor (BCR)
 
*
 
 signal, are predisposed to autoimmune dis-
ease (2–8). Cytoplasmic protein tyrosine phosphatases such
as SHP-1 also modulate BCR signaling (9) as exemplified
by the severe B cell lymphopenia and autoantibody pro-
duction of motheaten mice (10) that carry a debilitating
mutation in SHP-1 (11, 12).
The Lyn tyrosine kinase is involved in both positive and
inhibitory signaling pathways in B lymphocytes (13). Lyn’s
role in activation is mediated by the phosphorylation of
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Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; BM, bone
marrow; BrdU, 5-bromo-2
 
  
 
deoxyuridine; [Ca
 
2
 
 
 
]i, intracellular calcium
concentration; HEL, hen egg lysozyme; HRP, horseradish peroxidase;
PLC
 
 
 
2, phospholipase C
 
 
 
2; PY, phosphotyrosine. 
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tyrosine residues within immunoreceptor tyrosine-based
activation motifs of proteins such as Ig
 
 
 
, Ig
 
 
 
, and CD19,
and the subsequent recruitment of enzymes such as Syk,
phospholipase C
 
 
 
2 (PLC
 
 
 
2), and phosphatidyl inositol-3
kinase (14). As a balance, there is suppression of B cell
stimulation from Lyn-dependent phosphorylation of ty-
rosine residues within immunoreceptor tyrosine-based in-
hibitory motifs in proteins such as CD22, PIR-B, and
Fc
 
 
 
RIIb1, with the concomitant recruitment to the
plasma membrane of phosphatases such as SHP-1 and
SHIP-1 (15–21). Studies of Lyn-deficient mice have
shown that although Lyn is functionally redundant for the
positive regulation of signaling through the BCR, it is in-
dispensable for negative regulation of signaling. Lyn-defi-
cient B cells fail to recruit protein tyrosine phosphatases to
the plasma membrane due to defects in phosphorylation of
inhibitory receptors (16–19, 22). This results in defective
inhibitory signaling and as a consequence, Lyn-deficient B
cells are hyperresponsive to BCR stimulation and show
enhanced proliferation, calcium flux, and activation of the
mitogen-activated protein kinase pathway (15–19, 23).
The hyperresponsive B cell phenotype almost certainly
underpins the autoimmune disease that Lyn-deficient mice
develop (24, 25).
The dual nature of Lyn’s role in the regulation of B cell
signaling makes it a potentially critical target in analyzing
the development of B cell dysfunction. Having noted the
effects of the absence of Lyn activity (24), we now ask
what immunological consequences flow from the consti-
tutive engagement of both stimulatory and inhibitory sig-
naling pathways using a targeted gain-of-function Lyn
tyrosine kinase mutant (Lyn
 
up/up 
 
mice). Sustained up-
regulation of Lyn tyrosine kinase activity in Lyn
 
up/up 
 
mice
leads to the development of B cells that have down-regu-
lated surface IgM and costimulatory molecules, are refrac-
tory to stimulation with B cell mitogens, but show nor-
mal responses to T cell–derived signals. This phenotype is
reminiscent in some respects of that defined by a model
system of B cell anergy (26), although unlike this model,
which uses a single self-reactive BCR chronically engaged
by self-antigen, Lyn
 
up/up 
 
mice retain a full range of Ig
specificities. However, in contrast to this model, Lyn
 
up/up
 
B cells display constitutive tyrosine phosphorylation of
both positive and negative regulators of BCR signaling
and show exaggerated calcium fluxes in response to BCR
cross-linking. Thus, their phenotype appears to be a bal-
ance between chronic negative signaling and enhanced
positive signaling. Intriguingly, the mice develop circulat-
ing autoreactive antibodies, severe autoimmune glomeru-
lonephritis, and have a significantly shorter life expect-
ancy than wild-type mice. This eventual breakdown in
tolerance might be a result of enhanced positive signaling
overriding chronic negative signaling. These studies, to-
gether with those of Lyn-deficient mice, demonstrate the
central role of Lyn in maintaining the equilibrium be-
tween positive and negative signaling pathways in B lym-
phocytes and thus in the regulation of B cell tolerance and
the development of autoimmunity.
 
Materials and Methods
 
Mice.
 
Lyn
 
up/up 
 
mice (27) were housed in microisolators and
maintained as C57BL/6 
 
  
 
129/Sv intercrosses. Experiments
were performed in accordance with the National Health and
Medical Research Council of Australia (NH&MRC) guidelines
for animal experimentation.
 
Primary B Cells.
 
For Lyn expression studies, B cells were pu-
rified from Lyn
 
 
 
/
 
 
 
, Lyn
 
 
 
/up
 
, and Lyn
 
up/up 
 
mice by FACS
 
® 
 
sorting
using Abs to CD45R (B220) and IgM. Pre-B cells (B220
 
  
 
IgM
 
 
 
)
and immature B cells (B220
 
  
 
IgM
 
 
 
) were sorted from the bone
marrow (BM) using appropriate gates to exclude recirculating B
cells (B220
 
hi 
 
IgM
 
 
 
). B220
 
  
 
recirculating B cells were sorted from
the spleen.
To evaluate phosphorylation patterns, B cells were purified
from the spleens of Lyn
 
 
 
/
 
 
 
, Lyn
 
up/up
 
, and Lyn
 
 
 
/
 
  
 
mice using bio-
tinylated B220, streptavidin MicroBeads, and MiniMACS col-
umns (Miltenyi Biotec). B cell purity was always 
 
 
 
85%. Purified
B cells were resuspended to 10
 
7 
 
cells/ml in DME/1 mM vana-
date, prewarmed for 10 min at 37
 
 
 
C, and stimulated with 40 
 
 
 
g/
ml F(ab
 
 
 
)
 
2 
 
anti-IgM or 5 
 
 
 
g/ml intact rabbit anti–mouse IgM
(Jackson ImmunoResearch Laboratories) to coligate BCR and
Fc
 
 
 
RIIb1.
 
Flow Cytometric Analyses.
 
Cell preparation and FACS
 
® 
 
analy-
sis have been described (24). Cells were stained with the follow-
ing monoclonal Abs: RA3-6B2 (B220), 1D3 (CD19), R6-60.2
(IgM), 7G6 (CD21), HM79b (Ig
 
 
 
), Cy34.1 (CD22), 1G10
(CD80), GL1 (CD86), 53.7 (CD5), 30-H12 (Thy-1.2), goat
anti–mouse IgD, 187.1 (Ig
 
 
 
), JC5 (Ig
 
 
 
), S7 (CD43), B3B4
(CD23), M1/69 (HSA), and M5/114 (Ia
 
b,d
 
).
 
Proliferation Assays.
 
B cells, purified by FACS
 
® 
 
sorting, were
cultured at a density of 5 
 
  
 
10
 
5 
 
per ml in complete RPMI and
stimulated as previously described (24).
 
Colony Assays.
 
B cell progenitors were determined in 1 ml
semisolid 0.3% agar cultures (28). Colony formation was stimu-
lated by the combination of 200 ng/ml interleukin-7 (R&D Sys-
tems), 300 ng/ml Flt3 ligand, and 50 ng/ml stem cell factor (pro-
vided by N. Nicola, Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia). Plates were incubated at 37
 
 
 
C
in 7% CO
 
2 
 
in air and colonies were enumerated on day 5.
 
B Cell Life Span Studies.
 
5-bromo-2
 
  
 
deoxyuridine (BrdU;
Sigma-Aldrich) was administered in drinking water (0.50 mg/ml
BrdU, 1% glucose) to 8-wk-old Lyn
 
 
 
/
 
  
 
and Lyn
 
up/up 
 
mice for 7 d.
Single cell suspensions of spleen were depleted of RBCs and
stained for surface CD19 and nuclear BrdU (29). The data are
presented as the percentage of splenic CD19
 
  
 
B cells that are
BrdU
 
 
 
.
 
Intracellular Calcium Concentration ([Ca
 
2
 
 
 
]i) Measurement.
 
Spleen
cells were loaded with 2 
 
 
 
M Indo-1 (Molecular Probes Inc.) for
40 min at 37
 
 
 
C, stained with anti-B220, and resuspended at 10
 
7
 
cells/ml. Baseline fluorescence was established using an LSR
(Becton Dickinson) and BCR ligation initiated by the addition of
F(ab
 
 
 
)
 
2 
 
goat anti–IgM to a final concentration of 40 
 
 
 
g/ml. The
subsequent calcium flux was followed in B220
 
  
 
B cells (16).
 
ELISA and Immunizations.
 
Total serum Ig titers were deter-
mined by ELISA using goat anti–mouse Ig as a capture reagent
and developed either with biotinylated isotype-specific goat sera
and streptavidin-conjugated horseradish peroxidase (HRP), or
Abs directly conjugated with HRP (Southern Biotechnology As-
sociates, Inc.). Purified myeloma proteins (Sigma-Aldrich) were
used as standards. NP-KLH (100 
 
 
 
g in alum) and DNP-dextran
(10 
 
 
 
g in PBS; reference 30), were administered by intraperito-
neal injection. Serum titers of antigen-specific Ig were deter-
mined using an NP-specific ELISA (31). 
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Immunohistochemistry.
 
Spleens were embedded in OCT com-
pound and snap frozen in a bath of isopentane in liquid nitrogen.
5-
 
 
 
M cryostat sections were fixed in acetone and air-dried before
staining. Sections were rehydrated in PBS and endogenous perox-
idase activity was blocked by incubation with 0.3% H
 
2
 
O
 
2
 
. Sec-
tions stained to reveal B and T cells were first incubated with rat
anti–mouse B220 followed by HRP-conjugated mouse anti–
rat kappa (BD Biosciences). Sections were blocked with normal
rat serum and then stained with biotinylated rat anti–mouse CD3
(KT3) followed by streptavidin-conjugated alkaline phosphatase
(Southern Biotechnology Associates, Inc.). HRP was detected
with the AEC Substrate Kit for Peroxidase (Vector Laboratories)
and streptavidin with the VECTOR Blue Alkaline Phosphatase
Substrate Kit III (Vector Laboratories) in the presence of 2 mM le-
vamisole. Sections stained to reveal marginal zone B cells were first
incubated with HRP-conjugated goat anti–mouse IgM (Southern
Biotechnology Associates, Inc.) and biotinylated rat anti–mouse
IgD (clone 11-26C) followed by streptavidin-conjugated alkaline
phosphatase (Southern Biotechnology Associates, Inc.). Color de-
velopment was performed as it had been for B and T cell staining.
 
Histology and Immunofluorescence.
 
Histology was performed
exactly as previously described (24). Antinuclear Abs were de-
tected using sera at 1:100 (24). Kidneys were frozen in OCT im-
bedding compound and immune complexes were detected with
either fluoresceinated sheep anti–mouse Ig or fluoresceinated goat
anti–mouse IgG (Silenus Laboratories).
 
Cell Lysis, Immunoprecipitation, Western Blotting, and Kinase As-
says.
 
Cells were lysed for 30 min at 5 
 
  
 
10
 
7
 
/ml in buffer con-
taining 1% NP-40, 100 mM NaCl, 10 mM Tris-HCl, pH 7.5, 2
mM EDTA, 1 mM pefabloc, 1 mM aprotinin, and 1 mM sodium
orthovanadate, and nuclei were removed by centrifugation at
13,000 rpm. Protein concentrations of individual samples were
estimated using the BCA protein estimation kit (Pierce Chemical
Co.). Abs used for immunoprecipitation and Western blotting in-
cluded the following: rabbit anti–Lyn (Santa Cruz Biotechnol-
ogy, Inc.), mouse anti–phosphotyrosine (PY; 4G10; Upstate Bio-
technology), rabbit anti–SHP-1 (provided by H.-C. Cheng,
University of Melbourne, Melbourne, Australia), rat anti–CD22
(Cy34.1; BD Biosciences), rabbit anti–CD22 (provided by P.
Crocker, Dundee University, Dundee, United Kingdom), rabbit
anti–SHIP-1 (BD Biosciences), rabbit anti–PLC
 
 
 
2 (Q-20; Santa
Cruz Biotechnology, Inc.), and rabbit anti–Syk (provided by J.
Bolen, DNAX Research Institute of Molecular and Cellular Bi-
ology, Palo Alto, CA). Blots were developed with HRP-conju-
gated goat anti–rabbit, sheep anti–mouse antiserum, or protein A,
and the enhanced chemiluminescent system (Amersham Bio-
sciences). Autokinase reactions were performed as previously de-
scribed (24) using equalized amounts of Lyn protein as deter-
mined by densitometry of Western blots.
 
Results
 
Altered Lyn Protein Levels and Signaling in Lyn
 
up/up 
 
B
Cells.
 
To understand further how Lyn regulates signaling
thresholds, we have characterized B cells in mice expressing
a constitutively activated form of Lyn. These mice, desig-
nated Lyn
 
up/up
 
, carry a single point mutation (Y508F) in the
 
Lyn
 
 gene in a sequence that negatively regulates Lyn activ-
ity (27). Our previous biochemical studies on macrophages
from Lyn
 
up/up 
 
mice have demonstrated that total cellular
levels of Lyn protein are regulated by the activation state of
the enzyme. Lyn
 
Y508F 
 
protein is unstable and subject to
ubiquitination-dependent degradation (27). Consequently,
Lyn protein levels are reduced in Lyn
 
up/up 
 
B cells and to a
lesser extent in Lyn
 
 
 
/up 
 
B cells (Fig. 1 a). However, al-
Figure 1. Altered Lyn protein levels and signaling in primary B cells
from Lyn mutant mice. (a) Mature B cells were purified from the spleen
(Spleen B cells) and Pre-B and immature B cells were purified from the
BM of the indicated mice ( / , Lyn / ;  / , Lyn / ;  /up, Lyn /up;
up/up, Lynup/up) by FACS® sorting. Total cell lysates (TCL; 5   106 cell
equivalents for mature and Pre-B cells and 2.5   106 cell equivalents for
immature B cells) were immunoblotted with anti-Lyn Abs. The p56 and
p53 isoforms of Lyn are indicated. (b) Lyn kinase activity. Equalized levels
of Lyn protein (bottom, including densitometric measurements) immu-
noprecipitated from Lyn /  ( / ) and Lynup/up (up/up) B cells were
subjected to autokinase reactions. (c) Primary B cells from Lyn / , Lynup/up,
and Lyn /  mice were stimulated for 0 or 3 min with 40  g/ml F(ab )2
anti-IgM. 25  g TCLs were immunoblotted with anti-PY. The blot was
stripped and reprobed with anti–SHP-1 as a protein loading control. (d)
SHP-1 was immunoprecipitated from the indicated B cell lysates and
immunoblotted with anti-PY. The blot was stripped and reprobed with
anti–SHP-1 (middle) and an antiserum to CD22 (bottom) to demonstrate
coassociation of SHP-1 and phospho-CD22. CD22 (e), SHIP-1 (f), Syk
(g), and PLC 2 (h) were immunoprecipitated from the indicated B cell
lysates and immunoblotted with anti-PY. Blots were stripped and re-
probed with the indicated antibodies to ensure equal protein loading.1596 Lyn Is a Pivotal Regulator of B Cell Tolerance
though Lynup protein is diminished at all stages of B cell de-
velopment that were examined, the enzymatic activity of
LynY508F is enhanced two- to threefold (Fig. 1 b).
Unstimulated splenic Lynup/up B cells exhibit enhanced
tyrosine phosphorylation of specific proteins compared
with either Lyn /  or Lyn /  B cells (Fig. 1 c). After BCR
cross-linking, Lyn /  B cells show dramatically enhanced
numbers of tyrosine phosphorylated proteins, whereas
Lynup/up B cells show only a modest increase in already ele-
vated levels (Fig. 1 c). The increase in tyrosine phosphory-
lation in Lynup/up B cells after BCR stimulation might be
due to either the mobilization of Lyn into the BCR com-
plex or the recruitment and activation of other kinases such
as Fyn, Blk, and Syk. Lyn /  B cells show diminished anti-
gen-induced tyrosine phosphorylation compared with
Lyn /  B cells (23, 25). These results suggest that Lynup/up
B cells exist in vivo in a state of chronic stimulation.
The impact of the Lyn gain-of-function mutation on B
cell signaling was determined by measuring the phosphory-
lation status of key regulatory molecules (Fig. 1, d–h). We
first analyzed negative regulatory phosphatases and immune
inhibitory receptors known to be phosphorylated in a Lyn-
dependent fashion (16–19). Tyrosine phosphorylated SHP-1
was detectable in unstimulated Lyn /  B cells and at
clearly increased levels in unstimulated Lynup/up B cells (Fig.
1 d). Several tyrosine-phosphorylated proteins coprecipi-
tated with phospho–SHP-1 in unstimulated Lynup/up B cells
and to a proportionately lesser degree in unstimulated
Lyn /  and Lyn /  B cells (Fig. 1 d). The phosphorylation
of these proteins appears to be regulated by Lyn, with pre-
vious studies suggesting they include CD22, PIR-B,
p62dok, and BLNK (16–21, 32, 33). One coprecipitating
protein was identified as CD22 by reprobing the blot with
a CD22-specific antiserum (Fig. 1 d, bottom). Direct im-
munoprecipitation of CD22 shows that CD22 is hyperty-
rosine phosphorylated in unstimulated Lynup/up B cells (Fig.
1 e). Although the phosphorylation status of CD22 in-
creases after BCR stimulation of Lyn /  and Lynup/up B
cells, no such increase is seen in Lyn /  B cells (Fig. 1 e),
consistent with previous reports (16–19). Coligation of
Fc RIIb1 with the BCR leads to the inhibition of BCR-
mediated signaling largely via recruitment of the SH2-con-
taining inositol phosphatase SHIP-1 to the immunorecep-
tor tyrosine-based inhibitory motifs of Fc RIIb1 (34, 35).
SHIP-1 is hypertyrosine phosphorylated in unstimulated
Lynup/up B cells, but only visibly phosphorylated in Lyn / 
B cells after BCR stimulation (Fig. 1 f). In sharp contrast,
SHIP-1 is hypotyrosine phosphorylated in B cells from
Lyn /  mice, regardless of their stimulation status (Fig. 1 f).
In keeping with the close functional association between
SHIP-1 activation and Fc RIIb1 phosphorylation, the
phosphorylation status of Fc RIIb1 in Lyn / , Lynup/up,
and Lyn /  B cells mirrored that of SHIP-1 (not depicted).
Next, we examined the consequences of constitutive
Lyn activation on positive signaling pathways emanating
from the BCR. Syk kinase promotes B cell activation by
recruiting downstream targets such as PLC 2, the activa-
tion of which results in intracellular calcium flux (36).
Minimal tyrosine-phosphorylated Syk was observed in un-
stimulated Lyn /  B cells but the level increased dramati-
cally after BCR cross-linking. In contrast, phospho-Syk
was clearly detectable in unstimulated Lynup/up B cells, and
this was enhanced by BCR cross-linking (Fig. 1 g). As pre-
viously reported (23), the increase in Syk phosphorylation
after BCR cross-linking of Lyn /  B cells is less dramatic
than in controls (Fig. 1 g). Like Syk, tyrosine-phosphory-
lated PLC 2 was present in unstimulated Lynup/up B cells
and its level was increased by BCR ligation (Fig. 1 h). In
contrast, phospho-PLC 2 was only detectable in Lyn /  or
Lyn /  B cells after BCR stimulation (Fig. 1 h). Collec-
tively, these results demonstrate that both negative and pos-
itive signal transduction pathways in Lynup/up B cells are
constitutively activated.
Characteristics of Lynup/up Mice. To determine the effect
of the Lyn gain-of-function mutation on the B cell com-
partment, we performed analyses of primary and secondary
lymphoid tissue of 8-wk-old Lyn / , Lyn /up, and Lynup/up
mice (Figs. 2–4). Spleen cellularity was reduced in both
Lyn /up and Lynup/up mice whereas white blood cell counts
Figure 2. Cellularity and composition of lymphoid tissue in 8-wk-old
Lyn / , Lyn /up, and Lynup/up mice. (a) Nucleated cells in lymphoid tissue
in Lyn / , Lyn /up, and Lynup/up mice. Numbers represent per ml blood,
per whole spleen, per mesenteric lymph nodes, and per femur. (b) Num-
bers of conventional B cells, B1 cells, T cells, granulocytes (Gr), and
monocytes (Mo) in blood and (c) spleen of Lyn / , Lyn /up, and Lynup/up
mice. (d) Numbers of B and T cells in mesenteric lymph nodes of Lyn / ,
Lyn /up, and Lynup/up mice. (e) Numbers of recirculating B cells (Rec B),
immature B cells (Imm B), and Pre-B cells in the BM of Lyn / , Lyn /up,
and Lynup/up mice. Data in a–e is compiled from nine mice in three exper-
iments, except B cell and B1 cell numbers in blood and spleen, which
were compiled from six mice in two experiments. Data is mean   stan-
dard error. (f) BM B cell progenitors in Lyn /  and Lynup/up mice. Num-
bers are the mean   standard deviation for five mice of each genotype.
For a–f, white bars, Lyn / ; gray bars, Lyn /up; black bars, Lynup/up.1597 Hibbs et al.
were elevated in Lynup/up mice (Fig. 2 a), presumably due to
an increase in neutrophils (27). Lynup/up mice showed an
overall reduction in B cells: twofold in peripheral blood,
fivefold in spleen, 10-fold in lymph node, and 20-fold in
the recirculating B cell compartment of the BM (Fig. 2, b–e,
and Fig. 3 a). The B cell deficiency in heterozygous
Lyn /up mice was less severe than in homozygous mice, be-
ing approximately twofold in all lymphoid tissues. Numbers
of pro-B, pre-B, and immature B cells in the BM of Lynup/up
mice were not significantly different from controls (Fig. 2
e and Fig. 3 a) and B cell colony assays demonstrated no sig-
nificant change in the numbers of B cell progenitors (Fig. 2
f). Although the BM results suggest that B cell development
is not blocked in Lynup/up mice, levels of IgM on the surface
of immature Lynup/up B cells are reduced by  35% (not de-
picted). Peripheral B cells from Lynup/up and Lyn /up mice
also express lower surface IgM (Fig. 3, a and b), Ig , CD19,
CD21, and CD22 (Fig. 3 b), whereas IgD (Fig. 3 b) and
MHC class II (not depicted) are unaffected.
Peripheral blood and spleen from Lynup/up and Lyn /up
mice had a variable increase in a population of cells that
were IgM  B220lo (Fig. 4). Additional analyses of this pop-
ulation revealed the expression of CD19 and CD5 (Fig. 4).
Accordingly, these cells have been designated B1a B lym-
phocytes. Despite significant variation in the frequency of
B1a B cells between Lynup/up mice, on average we found
this population to be elevated approximately twofold in the
spleen and 10-fold in peripheral blood (Fig. 2, b and c).
B1a B cells were elevated in the peripheral blood of Lyn /up
mice but to a lesser degree than Lynup/up mice. Lynup/up
mice show a twofold increase in cellularity in the perito-
neum (not depicted), which is due to elevated numbers of
CD19  CD5  B220lo B1a cells (Fig. 4). B1b (CD5-B220lo)
and T cell populations appeared unaffected, whereas con-
ventional B cells were dramatically reduced in Lynup/up
peritoneum, in keeping with their diminution in other
lymphoid tissues (Fig. 4).
B Cell Function in Lynup/up Mice. The reduced popula-
tion of mature B cells in the periphery of Lynup/up mice
prompted us to investigate their functional capacity. B220hi
B cells were purified by FACS®  sorting from Lynup/up
spleen, thereby excluding B1 cells. Although Lyn /  B
Figure 3. Lynup/up  mice have reduced
levels of recirculating B cells. (a) Represen-
tative two-color fluorescence analysis of
lymphoid tissues from 8-wk-old Lyn / ,
Lyn /up, and Lynup/up  mice. Staining was
performed with Abs against B220 and IgM
to determine proportions of B cells and lev-
els of surface IgM. The mean fluorescence
intensity of IgM on peripheral blood B cells
from Lyn / , Lyn /up, and Lynup/up mice is
163, 101, and 103, respectively, on lymph
node B cells is 300, 163, and 213, respec-
tively, and on splenic B cells is 196, 122,
and 133, respectively. (b) Representative
single-color FACS®  analysis of splenic
B220  cells from 8-wk-old Lyn / , Lyn /up,
and Lynup/up mice. Staining was performed
with Abs against the indicated cell surface
molecules to assess expression level.1598 Lyn Is a Pivotal Regulator of B Cell Tolerance
cells proliferated well in response to 1  g/ml anti-IgM,
Lynup/up B cells were nonresponsive (Fig. 5 a). At 10  g/ml
anti-IgM, Lynup/up B cells gave a response that was seven-
fold lower than that of Lyn /  B cells (Fig. 5, a and b).
Lynup/up B cells were also poorly responsive to LPS (Fig. 5
b), but could respond normally to CD40 ligand plus inter-
leukin-4 stimulation (Fig. 5, a and b). These results high-
light the differences between Lynup/up and Lyn /  B cells,
which exhibit heightened responses to anti-IgM stimula-
tion (15, 23).
B Cell Turnover in Lynup/up Mice. The decreased num-
bers of peripheral B cells in Lynup/up mice suggested an in-
creased rate of B cell turnover. To measure this, we exam-
ined the incorporation of BrdU-labeled B cells into the
splenic compartment. After 7-d labeling, 28% of CD19  B
cells in the spleens of Lyn /  mice had been replaced by
BrdU  B cells compared with nearly 60% in Lynup/up
spleens (Fig. 5 c). These results reveal a far greater propor-
tion of short-lived B cells in Lynup/up mice, suggesting de-
fects in either B cell survival or maturation.
Calcium Signaling in Lynup/up B Cells. Although Lynup/up
B cells showed dramatic diminution of in vitro proliferative
responses and constitutive activation of inhibitory signaling
pathways, the enhanced tyrosine phosphorylation of Syk
and PLC 2 in resting Lynup/up B cells suggested that some
positive signaling pathways remained functional. There-
fore, we investigated calcium responses in B cells from
Lyn /  and Lynup/up mice. Upon BCR cross-linking, B
cells from both strains of mice showed a prompt rise in
[Ca2 ]i followed by a gradual decline (Fig. 5 d). The maxi-
mum amplitude reached after cross-linking IgM was con-
sistently higher in Lynup/up B cells (Fig. 5 d), possibly re-
flecting the hyperactivation of PLC 2 (Fig. 1 h). Although
no significant differences in the kinetics of decline was
found, variable elevation in basal [Ca2 ]i was observed
(Fig. 5 d). Thus, the calcium response of Lynup/up B cells
shows that BCR cross-linking dependent positive signaling
pathways are enhanced despite the presence of constitu-
tively active Lyn and engagement of inhibitory enzymes
and receptors.
Immunoglobulin Levels in Lynup/up Mice. To determine if
the low number of peripheral B cells in Lynup/up and Lyn /up
mice and their impaired in vitro responses had functional
corollaries, serum immunoglobulin levels in Lynup/up and
Lyn /up mice were investigated. Surprisingly, Lynup/up mice
had two- to threefold elevated levels of serum IgM (Fig. 6
a), possibly reflecting their increased numbers of B1a B
cells. However, although B1 B cells also secrete IgA and
IgG3 (37), Lyn /up and Lynup/up mice had normal serum
IgA levels and 10-fold reduced serum IgG3 (Fig. 6 a).
Lynup/up mice also had 10-fold lower levels of serum IgG1
compared with control mice, whereas levels of serum
IgG2b were unchanged (Fig. 6 a). Serum IgE levels were
reduced by 10-fold in both Lyn /up and Lynup/up mice com-
pared with control mice (Fig. 6 a). This contrasts with Lyn-
deficient mice, which have 10-fold higher IgE levels than
control mice and heightened sensitivity to interleukin-4
signaling (38).
Immune Responses in Lynup/up Mice. Next, we examined
the consequences of the Lynup/up mutation on the B cell re-
sponse to antigen. Lyn / , Lyn /up, and Lynup/up mice were
challenged with the T cell–independent antigen DNP-
dextran, and levels of anti-TNP Ab (cross-reactive with
DNP) in serum were measured at regular times after im-
munization. Both Lyn /up and Lynup/up mice had reduced
levels of anti-TNP Ab 5 d after immunization compared
Figure 4. Lynup/up mice have increased numbers of B1 cells. Two-color
fluorescence analysis of blood, spleen, and peritoneal lymphoid cells from
8-wk-old Lyn /  and Lynup/up mice. Blood and spleen cells were stained
with B220 and IgM to identify IgM  B220lo B1 cells. Spleen cells were
also stained with CD19 and CD5 Abs to show CD19hi CD5  B1a cells in
Lynup/up spleen (boxed region). Peritoneal cells were stained using Abs to
B220 and CD5 to identify: Region 1, T cells (Lyn / , 14.4%; Lynup/up,
13.0%), Region 2, B1a B cells (Lyn / , 34.6%; Lynup/up, 76.1%), Region
3, B1b B cells (Lyn / , 9.4%; Lynup/up, 4.3%), and Region 4, B2 cells
(Lyn / , 31.7%; Lynup/up, 1.8%). Alternatively, peritoneal B1a cells were
revealed with Abs to CD19 and CD5.1599 Hibbs et al.
with Lyn /  mice, but by 10 and 17 d after immunization,
levels of anti-TNP Ab were normal (Fig. 6 b). This unex-
pected response to a T cell–independent antigen might be a
reflection of the larger B1 B cell population in Lyn /up and
Lynup/up mice, because B1 B cells have been reported to re-
spond to   1–3 dextran (39).
T cell–dependent immune responses in Lyn / , Lyn /up,
and Lynup/up mice were examined after immunization with
NP-KLH. Compared with Lyn /  animals, both Lyn /up
and Lynup/up mice had significantly lower titers of NP-spe-
cific IgG1 7 d after immunization (Fig. 6 c). The titers of
NP-specific Ab in all groups of mice increased during the
next 2 wk and were maximal 3 wk after immunization, al-
though the titers in Lyn /up and Lynup/up mice were only 10
and 5% of control levels, respectively. The proportion of
high affinity anti-NP Ab was the same in all groups (Fig. 6
d). In addition, all mice responded to secondary challenge,
although the level of Ab in Lyn /up and Lynup/up mice never
reached that made by Lyn /  mice (not depicted). The re-
duced levels of NP-specific Ab in Lyn /up and Lynup/up
mice may reflect either their reduced numbers of mature B
cells or the consequences of constitutive activation of nega-
tive regulatory pathways in the responding B cells.
Spleen and Lymph Node Histology in Lynup/up Mice. To
determine if spleen or lymph node architecture was dis-
Figure 5. Proliferation, turnover, and calcium re-
sponses of Lyn /  and Lynup/up B lymphocytes. 5   104
FACS®-sorted splenic B cells from Lyn /  mice (open
bars) and Lynup/up mice (solid bars) were cultured in the
presence of (a) the indicated concentrations of anti-IgM
or CD40 ligand plus interleukin-4 for 2 d, and in (b) the
indicated concentrations of LPS, 10  g/ml anti-IgM, or
CD40 ligand plus interleukin-4 for 3 d. (c) Turnover of
peripheral B lymphocytes by incorporation of BrdU.
Spleen cells from BrdU-treated Lyn /  mice (open bars)
and Lynup/up mice (solid bars) were stained for surface
CD19 and intranuclear BrdU to determine the percent-
age of BrdU  B cells. Data is representative of two ex-
periments in which five mice of each genotype were an-
alyzed. (d) Changes in [Ca2 ]i induced by cross-linking
surface IgM on Indo-1–loaded spleen cells from Lyn / 
and Lynup/up mice. The fluorescence ratio of the cells
(fl5/fl6) was measured by flow cytometry and B cells
were identified by counter-staining with anti-B220.
Cross-linking reagent was added at 60 s (arrow) and the
measurement continued for 300 s Two representative
examples from three experiments involving six mice of
each genotype are shown with the response of Lyn /  B
cells depicted in blue and Lynup/up B cells in red.
Figure 6. Immunoglobulin levels and immune responses. (a) Levels of
immunoglobulin isotypes in the serum of 8–20 unchallenged Lyn / ,
Lyn /up, and Lynup/up mice. (b) Specific IgM response of a group of six
Lyn / , Lyn /up, and Lynup/up mice at the indicated times after immuniza-
tion with 10  g DNP-dextran. Data is representative of two experiments.
(c) Specific IgG1 response of a group of six Lyn / , Lyn /up, and Lynup/up
mice at the indicated times after immunization with 100  g NP-KLH.
Data is representative of two experiments. (d) High affinity IgG1 response
of the group of mice indicated in c. Data is representative of two experi-
ments. Data are mean   standard deviation. For a–d, white bars, Lyn / ;
gray bars, Lyn /up; black bars, Lynup/up.1600 Lyn Is a Pivotal Regulator of B Cell Tolerance
rupted in Lynup/up mice, histological sections were exam-
ined. Like Lyn /  spleen, Lynup/up spleen contained lym-
phoid follicles, although germinal centers were not
apparent and there was a loss of red/white pulp definition
(Fig. 7, a–d). Surprisingly, large numbers of multinucleate
giant cells were present within lymphoid follicles and in
follicle marginal zones (Fig. 7, b and d). Multinucleate gi-
ant cells were also found in lymph nodes, liver, and within
the thymus where they were concentrated around the me-
dulla/cortex interface (not depicted). SIRP , a protein that
is tyrosine phosphorylated in a Lyn-dependent manner
(27), is reported to be involved in macrophage fusion (40),
suggesting that this phenotype may arise through its disreg-
ulated activity in Lynup/up macrophages.
To determine whether splenic white pulp was disorga-
nized in Lynup/up mice, sections were analyzed by immuno-
histochemistry (Fig. 7, e–j). B220 and CD3 staining con-
firmed the substantial deficit of B cells in Lynup/up spleen
and moderate reduction in Lyn /up spleen. Formation of
the B cell follicle is abnormal in Lynup/up spleen with the
majority of B cells residing in the outer periarteriolar lym-
phocytic sheath area (Fig. 7 g), a distribution consistent
with the activated phenotype (41, 42). IgMhi IgDlo marginal
zone B cells were absent from Lynup/up spleen and reduced
in number in Lyn /up spleen (Fig. 7, i and j). Increased
numbers of cytoplasmic IgMhi cells that are presumably
plasma cells were contained within the red pulp of Lynup/up
spleen (Fig. 7 j). Although the absence of CD21hi IgMhi
marginal zone B cells in Lynup/up spleen (not depicted) sug-
gests a failure in differentiation, the involvement of Lyn in
the generation of this population is consistent with a previ-
ous report (43).
Figure 7. Histology, immunohistochemis-
try, survival, autoantibodies, and immunofluo-
rescence analysis of Lyn /  and Lyn mutant
mice. (a) Spleen from a Lyn /  mouse showing
lymphoid follicles with germinal centers. (b)
Spleen from a Lynup/up mouse showing lym-
phoid follicles with numerous multinucleate gi-
ant cells (arrows). (c) Higher power view of
Lyn /   spleen. (d) Higher power view of
Lynup/up  spleen depicting multinucleate giant
cells within a lymphoid follicle (arrows). Spleen
sections from (e) Lyn / , (f) Lyn /up, and (g)
Lynup/up mice stained with B220 and CD3 to
detect B (brown) and T cells (blue). Spleen sec-
tions from (h) Lyn / , (i) Lyn /up, and (j)
Lynup/up mice stained with IgM (brown) and
IgD (blue) to detect marginal zones (IgMhi). (k)
Kaplan-Meier survival curve showing the per-
cent survival of a cohort of 20 male and 20 fe-
male Lyn / , Lyn /up, Lynup/up, and Lyn / 
mice. (l) Male Lynup/up mouse of 10 mo of age
showing extensive edema. (m) Low power
view of a renal cortex from a Lyn /  mouse
showing several normal glomeruli. (n) Low
power view of Lynup/up renal cortex showing
two very enlarged sclerotic glomeruli. (o) High
power view of Lyn /  renal cortex showing a
normal glomerulus. (p) High power view of
Lynup/up renal cortex showing a severely dam-
aged glomerulus with lobularity and sclerosis.
View of the renal cortex from (q) Lyn /  and
(r) Lynup/up mice stained with anti-Ig. Glomer-
uli are indicated with arrows. View of the renal
cortex from (s) Lyn /  and (t) Lynup/up mice
stained with anti-IgG. Glomeruli are indicated
with arrows. Immunofluorescence analysis of
HEp-2 cells stained with antisera from (u) fe-
male Lyn / , (v) male Lyn /up, (w) female
Lynup/up, and (x) male Lynup/up mice.1601 Hibbs et al.
Pathology in Aged Lynup/up Mice. To determine if Lynup/up
mice develop any pathology during the course of their lives,
cohorts of control and Lyn mutant mice were aged (Fig. 7 k).
In these groups the median survival of male and female Lynup/up
mice was 310 and 575 d, respectively (Fig. 7 k). In contrast,
male and female Lyn /  mice had similar survival rates of 430
and 460 d, respectively (Fig. 7 k). Male and female mice car-
rying a single copy of the Lyn gain-of-function mutation had
median survival rates of 660 and 770 d, respectively, signifi-
cantly better than Lynup/up mice. However, although the me-
dian survival of female Lyn /up mice was similar to the me-
dian survival of 710 d for female Lyn /  mice, it is clear that
male Lyn /up mice have a poorer survival than male Lyn / 
mice (median survival of 780 d; Fig. 7 k).
From  8 mo of age, a proportion of male Lynup/up mice
showed signs of edema (Fig. 7 l) and respiratory distress,
whereas others appeared emaciated. Mice with edema had
fluid collection under the skin and in pleural and peritoneal
cavities, and their hearts were enlarged. Histological exam-
ination of solid organs from both edematous and emaciated
Lynup/up mice demonstrated severe renal disease (Fig. 7,
m–p). Kidneys from these mice exhibited glomerulonephrop-
athy, similar to membranous glomerulonephritis in hu-
mans. Glomeruli were enlarged with a relative lack of
cellularity and showed thickened glomerular capillary
basement membranes. In some cases, glomerulosclerosis
was noted (Fig. 7, n and p). Periodic acid silver staining
showed the presence of periodic acid silver–positive mate-
rials within the capillary basement membrane (not de-
picted). These severe kidney changes correlated with renal
failure and are almost certainly the cause of the severe
edema observed in the majority of older male mice. Be-
cause this form of glomerulonephritis in humans is associ-
ated with the nephrotic syndrome, characterized by severe
edema, it is likely that the edema is a direct affect of the
membranous-type glomerulonephritis. Although it is clear
that male Lynup/up mice succumb to renal failure at an ear-
lier age than female Lynup/up mice (Fig. 7 k), female Lynup/up
mice do show evidence of mild glomerular disease but
the disease is less severe and of later onset.
The animals in the survival cohort were of a mixed
C57BL/6   129/Sv genetic background and because ge-
netic background can influence development of autoim-
mune disease, we subsequently backcrossed the Lynup muta-
tion for 10 generations onto the C57BL/6 background.
Although only a limited number of mice have been available
for analysis, Lynup/up mice on the C57BL/6 background de-
velop edema and membranous glomerulonephropathy with
the same sex bias as mice on the mixed genetic background
(not depicted).
Lynup/up Mice Have Circulating Autoreactive Antibodies and
Display Immune Complex Deposition in the Kidney. The
kidney abnormalities in aged Lynup/up mice are reminiscent
of the lupus-like disease we and others observed in Lyn-
deficient animals (24, 25). To determine whether the renal
disease in aged Lynup/up mice was due to an underlying au-
toimmune disease, we stained frozen sections of kidney
with Abs to Ig (Fig. 7, q and r) and with Abs to IgG (Fig. 7,
s and t). Small patches of immune complexes could be ob-
served in the glomeruli of Lyn /  mice but these were not
composed of the more pathogenic IgG Abs (Fig. 7, q and
s). In kidney sections of two different Lynup/up mice, strong
glomerular staining was observed with Abs to Ig and IgG
(Fig. 7, r and t). The presence of immune complexes in
Lynup/up glomeruli was confirmed by electron microscopy
through the identification of subendothelial and mesangial
electron dense deposits and widespread epithelial cell foot
process effacement (not depicted).
The presence of serum autoantibodies was tested by
staining slides of HEp-2 cells with serum from five Lyn / ,
Lyn /up, and Lynup/up mice of each sex. Serum from male
and female Lyn /  animals showed weak or no staining
(Fig. 7 u and unpublished data), whereas serum from five
female Lynup/up mice and four out of five male Lynup/up
mice had antinuclear Abs (Fig. 7, w and x). Thus, although
autoantibodies are clearly present in female Lynup/up serum,
for unknown reasons these animals develop a milder form
of glomerulonephritis than their male counterparts. Anti-
nuclear Abs were also detected in Lyn /up mice, although
not until  2 yr of age (Fig. 7 v). These data imply that the
pathology associated with Lynup/up mice is a consequence of
circulating autoreactive antibodies.
Discussion
To understand how the Lyn tyrosine kinase regulates
signaling thresholds within B cells, we have analyzed mice
carrying a gain-of-function mutation in the endogenous
Lyn gene (Lynup/up mice). Lyn has been implicated in both
positive and negative signaling pathways in B lymphocytes
(14) and, although Lyn has the capacity to both activate
and inhibit BCR signaling depending on its substrates,
these two functions need to be tightly regulated in order to
achieve an appropriate signal transduction response. There-
fore, it was of interest to determine the effect of simulta-
neous sustained activation by Lyn of both stimulatory and
inhibitory signaling pathways. Our biochemical studies
demonstrate that Lynup/up B cells display constitutive phos-
phorylation of both positive and negative regulators of
BCR signaling. However, although Lynup/up B cells do not
proliferate in response to B cell–derived signals, fail to de-
velop a blast-like appearance, and induce activation mark-
ers in response to BCR cross-linking, they show exagger-
ated BCR-dependent calcium fluxes.
Mechanisms of B cell tolerance have been explored us-
ing model systems in which immunoglobulin transgenic B
cells develop in the continuous presence of their ligand.
These systems have shown that self-reactive B cells are de-
leted in the BM at an immature stage when the avidity of
the interaction is high (44–46) but appear in the periphery
in a state of arrested activation, a condition termed anergy
(47, 48), when the avidity is moderate. Intriguingly, sev-
eral of the phenotypic and functional characteristics of
Lynup/up B cells are reminiscent of the anergic B cells ob-
tained from a model system in which mice express trans-
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high affinity, HEL-specific Ab (26). Such tolerant HEL-
specific B cells, chronically engaged by circulating self-
antigen, down-regulate surface IgM, but not IgD (49), have
reduced splenic half-life (50), and although defective in
BCR-mediated functions such as induction of tyrosine
phosphorylation (51), can still respond to T cell–mediated
signals (52). Tolerant HEL-specific B cells show elevated
basal calcium oscillations but in vitro ligation with HEL
fails to evoke a large, transient increase in [Ca2 ]i (53).
Lynup/up B cells show down-regulation of surface IgM (Fig.
3), defective BCR-induced responses (Fig. 5, a and b),
normal responses to T cell–derived signals (Figs. 5 and 6),
and reduced splenic B cell half-life (Fig. 5 c), all of which
are reminiscent of anergic B cells. Spleens from both
Lynup/up mice and double transgenic HEL/anti-HEL mice
show a striking loss of marginal zones (Fig. 7; reference
54). The abnormal distribution of B cells within splenic
white pulp (Fig. 7) is also similar to the self-reactive B cells
in the HEL system (42, 55). In contrast, Lynup/up B cells
show elevated constitutive tyrosine phosphorylation that
remains inducible after BCR stimulation (Fig. 1) and
heightened calcium responses after BCR ligation (Fig. 5
d). Thus, although Lynup/up B cells display cellular charac-
teristics associated with immunological unresponsiveness,
their molecular profile suggests that this is achieved by ac-
tively balancing BCR-associated positive and negative
regulatory pathways.
What then causes the eventual breakdown in tolerance
in Lynup/up mice? Although the exact cause is unknown, the
following possibilities are consistent with our data. First,
the diminished BCR responsiveness of Lynup/up B cells may
select for a higher than normal degree of self-reactivity
amongst the peripheral B lymphocyte population. Such se-
lective recruitment of self-reactivity is apparent in mice
whose B cells are unresponsive to BCR ligation due to the
absence of CD45 (56). Second, the molecular silencing of
self-reactive B cells that usually accompanies their appear-
ance in the periphery (51) is not enforceable in Lynup/up B
cells. In sharp contrast to CD45-deficient mice (56) and
other models of B cell anergy (53), Lynup/up B cells retain
the ability to initiate and sustain both tyrosine phosphoryla-
tion and calcium flux after BCR ligation. The discordance
between repertoire selection on the one hand and BCR-
associated signal transduction on the other may eventually
allow sufficient self-reactive cells to escape their anergic
state and initiate disease.
A second pathway to autoimmunity in Lynup/up mice
may lie in their elevated numbers of B1 cells; a cell type
that is associated with the production of natural antibodies
and connected with the induction of autoimmunity (57).
8–10-fold increased numbers of B1a cells are consistently
found in the peritoneal cavities of Lynup/up mice and less
frequently, in the circulation and other tissues. Finding
more B1 cells in Lynup/up spleen might be significant, given
the recent report of the location-dependent responsiveness
of such cells (58). Lynup/up mice have slightly elevated levels
of IgM, but reduced levels of most other Ig isotypes, sug-
gesting that the IgM may well derive from the elevated B1
cell population. Perhaps not too surprisingly, Lynup/up mice
also have higher levels of intestinal IgM (not depicted). It
will be important to determine the etiology of autoim-
mune disease in Lynup/up mice and transplantation studies
with B1 cells may define their role in the disease process.
Although the nature of the autoimmune disease that Lynup/up
mice develop indicates that B cells play an important role
in its pathogenesis, they are unlikely to act alone. T cells,
which do not express Lyn, must also be recruited into the
disease to give rise to the pathological IgG-mediated con-
dition that is manifest by these mice. Therefore, it is rele-
vant that Lynup/up B cells remain receptive to T cell–derived
stimuli. Other cell types such as macrophages may also
contribute to the disease process.
It is interesting to compare and contrast the phenotypes
of Lynup/up and Lyn-deficient B cells, and as one may pre-
dict, they are almost diametrical. Lynup/up B cells exhibit
dramatically reduced proliferative responses to BCR stimu-
lation, whereas Lyn-deficient B cells are hyperresponsive to
anti-IgM (15, 23). Lyn-deficient B cells have relatively
normal but delayed patterns of antigen-induced protein
tyrosine phosphorylation (15, 23), whereas unstimulated
Lynup/up B cells show constitutive tyrosine phosphorylation
of both positive and negative regulators of BCR signaling
and have only modest increases in phosphorylation after
BCR cross-linking. B1a B cells are elevated in Lynup/up
mice but reduced in Lyn-deficient mice (unpublished data),
and serum Ig levels are reduced or relatively unchanged in
Lynup/up mice but elevated in Lyn-deficient mice (24, 25,
38). Notwithstanding these many differences, both strains
of mice show a breakdown in self-tolerance and develop
circulating autoreactive antibodies and severe lupus-like
glomerulonephritis. These studies clearly demonstrate that
Lyn is a key regulator of signaling in B lymphocytes and
suggest that any imbalance of signaling, either by deletion
or constitutive activation of Lyn, results in severe autoim-
munity. Given the central role of Lyn in regulating toler-
ance in mouse models, its contribution to autoimmune dis-
ease in humans warrants close examination.
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